MédiMabs Clones

A blog about science

When Brain Beavers Build Too Big: Breaking the Glycogen Dam in Tauopathy

In the complex landscape of neurodegenerative disorders like Alzheimer’s disease and frontotemporal lobar degeneration (FTLD), an interesting case of metabolic misbehavior has been identified by a research team at the Buck Institute of Research on Aging (1). Think of glycogen, the brain’s emergency energy reserve, as the building material. In affected neurons, the tau protein […]

MédiMabs’ Team

Dec 12 •

Latest articles

Akt activation pathway

Akt is a subfamily of serine/threonine kinases (Protein Kinase B) that includes AKT1, AKT2, and AKT3. Akt resides in the...

MédiMabs’ Team • Oct 26 • 2 minutes read

IDIGH symposium and product show

(IDIGH) has been developed at McGill University to maximize the research effort with a translational focus. We are proud to...

MédiMabs’ Team • Oct 18 • 2 minutes read

Montreal Immunology Meetings

Montreal Immunology Meetings are a local initiative from researchers in immunology related fields. They organize small presentations from experts on...

MédiMabs’ Team • Oct 12 • 1 minutes read

DDRs, a family of 2 proteins, are key in cell-to-microenvironment communication

The cellular microenvironment can modulate intracellular pathways, these interactions can occur in normal or physiopathological conditions. However, if pro-survival molecules...

MédiMabs’ Team • Oct 03 • 2 minutes read

MédiMabs is presenting StabiliMABS

StabiliMABS is a two part option you can apply on any custom hybridoma project. We would first apply StabiliMABS-1 on early positive clones...

MédiMabs’ Team • Sep 27 • 2 minutes read

EGFRs in cancer

Epithelial Growth Factor Receptors are a family of receptor tyrosine kinase well studied for their role in cancer. (1) They have been...

MédiMabs’ Team • Sep 27 • 2 minutes read

SOD1 and ALS

The discovery of the implication of in familial ALS has turned 25 this year.(1) ALS was discovered more than 100 years ago...

MédiMabs’ Team • Sep 19 • 2 minutes read

CRCHUM show October 11th 2018

It will be our pleasure to meet you at our booth during the event on October 11th at the CRCHUM in Montréal. We will...

MédiMabs’ Team • Sep 19 • 1 minutes read

Neurosciences

Research on neurodegenerative disease has always been important at MédiMabs. Partly because two of our founders have dedicated their career to this...